Aztreonam for inhalation solution (AZLI) in patients with cystic fibrosis, mild lung impairment, and P. aeruginosa-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Aztreonam for inhalation solution (AZLI) in patients with cystic fibrosis, mild lung impairment, and P. aeruginosa

Published:2011-07 Issue:4 Volume:10 Page:234-242
ISSN:1569-1993
Container-title:Journal of Cystic Fibrosis
language:en
Short-container-title:Journal of Cystic Fibrosis

Author:

Wainwright C.E.,Quittner A.L.,Geller D.E.,Nakamura C.,Wooldridge J.L.,Gibson R.L.,Lewis S.,Montgomery A.B.

Funder

Gilead Sciences, Inc

NIH General Clinical Research Center

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Pediatrics, Perinatology and Child Health

Reference16 articles.

1. State of the art: pathophysiology and management of pulmonary infections in cystic fibrosis;Gibson;Am J Respir Crit Care Med,2003

2. 2008 annual data report to the center directors;Cystic Fibrosis Foundation Patient Registry,2009

3. Longitudinal analysis of pulmonary function decline in patients with cystic fibrosis;Corey;J Pediatr,1997

4. Cystic fibrosis pulmonary guidelines. Chronic medications for maintenance of lung health;Flume;Am J Respir Crit Care Med,2007

5. Consensus working group. Inhaled medication and inhalation devices for lung disease in patients with cystic fibrosis: a European consensus;Heijermann;J Cyst Fibros,2009

Cited by 85 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Continuously producible aztreonam-loaded inhalable lipid nanoparticles for cystic fibrosis-associated Pseudomonas aeruginosa infections – Development and in-vitro characterization;Biomaterials Advances;2025-01

2. Rocket-miR, a translational launchpad for miRNA-based antimicrobial drug development;mSystems;2023-12-21

3. Antibiotic strategies for eradicating Pseudomonas aeruginosa in people with cystic fibrosis;Cochrane Database of Systematic Reviews;2023-06-02

4. Current and Emerging Inhaled Antibiotics for Chronic Pulmonary Pseudomonas aeruginosa and Staphylococcus aureus Infections in Cystic Fibrosis;Antibiotics;2023-02-28

5. Biofilm formation in acute and chronic respiratory infections caused by nosocomial gram-negative bacteria;Microbial Biofilms;2023

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3